Methods, compositions, and kits for detecting protein aggregates

US9518296B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9518296-B2
Application numberUS-201313975056-A
CountryUS
Kind codeB2
Filing dateAug 23, 2013
Priority dateMay 3, 2006
Publication dateDec 13, 2016
Grant dateDec 13, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present teachings provide methods, compositions, and kits for detecting the presence of protein aggregates. In some embodiments, the protein aggregate is treated with a labeled precursor, and the labeled precursor is incorporated into the protein aggregate to form a labeled protein aggregate. The labeled protein aggregate is then measured, thus detecting the presence of the protein aggregate. In some embodiments, the labeled protein aggregate is detected by interaction of labeled precursors, for example by a proximity ligation assay.

First claim

Opening claim text (preview).

We claim: 1. A kit for detecting a protein aggregate in a sample comprising: a first soluble precursor molecule; a second soluble precursor molecule; and an oligonucleotide splint, wherein the first soluble precursor molecule is attached to a first oligonucleotide, and wherein the second soluble precursor molecule is attached to a second oligonucleotide, and wherein the first and second soluble precursor molecules are protein moieties of the protein aggregate prior to aggregation. 2. The kit according to claim 1 further comprising a ligase. 3. The kit according to claim 1 further comprising reagents for a polymerase chain reaction (PCR), wherein the reagents for the PCR comprise a first primer and a second primer, wherein the first primer corresponds to the first oligonucleotide of the first soluble precursor molecule and wherein the second primer corresponds to the second oligonucleotide of the second soluble precursor molecule. 4. The kit of claim 1 , where the first soluble precursor molecule and the second soluble precursor molecule are Sup35. 5. The kit of claim 1 , where the first soluble precursor molecule and the second soluble precursor molecule are beta amyloid protein. 6. The kit of claim 1 , where the first soluble precursor molecule and the second soluble precursor molecule are huntingtin. 7. The kit of claim 1 , where the first soluble precursor molecule and the second soluble precursor molecule are alpha-synuclein. 8. The kit of claim 1 , where the first soluble precursor molecule and the second soluble precursor molecule are bovine prion protein. 9. The kit of claim 1 , where the reagents for PCR further comprise one or more of deoxynucleotide phosphates, thermostable DNA polymerase, one or more PCR buffers. 10. The kit of claim 1 , wherein the first and second soluble precursor molecules are correctly folded proteins that are not yet in the conformation present in a protein aggregate. 11. The kit of claim 1 , wherein the protein aggregate is a naturally occurring homo-multimeric protein complex. 12. The kit of claim 1 , wherein the protein aggregate comprises abnormal mis-folded proteins. 13. The kit of claim 1 , wherein the protein aggregate comprises aggregated prion particles. 14. The kit of claim 13 , wherein the aggregated prion particles comprise yeast prion proteins selected from Sup35, Ure2 and Rnq1, human prion proteins, bovine prion proteins, or sheep prion proteins. 15. The kit of claim 1 , wherein the protein aggregate detected by the kit is selected from aggregated yeast prion proteins, human prion proteins, beta amyloid protein, tau proteins, huntingtin protein, alpha-synuclein protein, or bovine prion protein.

Assignees

Inventors

Classifications

  • C07K14/47Primary

    from mammals · CPC title

  • characterised by the detection means (C12Q1/6804 takes precedence) · CPC title

  • Alzheimer's disease; Amyloid plaque core protein · CPC title

  • C12Q1/6876Primary

    Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes · CPC title

  • Probe or oligonucleotide ligation · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9518296B2 cover?
The present teachings provide methods, compositions, and kits for detecting the presence of protein aggregates. In some embodiments, the protein aggregate is treated with a labeled precursor, and the labeled precursor is incorporated into the protein aggregate to form a labeled protein aggregate. The labeled protein aggregate is then measured, thus detecting the presence of the protein aggregat…
Who is the assignee on this patent?
Applied Biosystems Llc
What technology area does this patent fall under?
Primary CPC classification C07K14/47. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).